Home » Topics » Regulatory

Regulatory
RSS

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

AstraZeneca completes MRP in E.U. for Symbicort Turbuhaler in COPD

Feb. 12, 2003

FDA approves Zoloft for social anxiety disorder

Feb. 12, 2003

Fludara receives E.U. approval as first-line treatment for B-CLL

Feb. 11, 2003

Positive phase III results obtained for Metformin GR in type 2 diabetes

Feb. 5, 2003

First biologic therapy for psoriasis approved by FDA

Feb. 4, 2003

First treatment for acute ischemic stroke cleared for use in Europe

Jan. 29, 2003

Nabi-HB accepted for priority review for use in liver transplantation

Jan. 27, 2003

Amgen submits sBLA for Enbrel in ankylosing spondylitis

Jan. 24, 2003

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Jan. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...